Actively Recruiting
A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
Led by Guangdong Provincial People's Hospital · Updated on 2026-01-15
90000
Participants Needed
8
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Chronic kidney disease (CKD) involves damage to the kidneys' structure or function and affects a significant portion of the population in China, with a prevalence of 10.8%. CKD not only leads to severe kidney failure requiring treatments like dialysis but also raises the risk of cardiovascular diseases, placing a heavy burden on individuals and the healthcare system. This research aims to improve understanding of CKD occurrence, progression, treatment, prognosis, and risk factors in the Chinese population through a large-scale, real-world observational study. The study is a multi-center, prospective observational registry involving participants from various centers across mainland China. It collects and integrates standardized data to efficiently analyze CKD patterns and outcomes. The study includes both CKD patients and individuals with risk factors such as hypertension, diabetes, or hyperlipidemia, as well as healthy participants, to allow broad representation and subgroup analysis. The study is designed to cover a large sample size and account for potential loss to follow-up. Participants will be observed over up to 5 years to monitor the development of CKD in non-CKD individuals and the progression of disease in those with CKD. Researchers will track changes in kidney function, albuminuria levels, and composite endpoints including disease progression and mortality. Data collection includes clinical assessments and laboratory measurements to evaluate disease markers and outcomes. The study offers long-term monitoring to better understand CKD dynamics and inform prevention and control strategies.
CONDITIONS
Brief Title
A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with chronic kidney disease (CKD) as defined by KDIGO 2012 guidelines
- Non-CKD patients with hypertension, diabetes, high cholesterol, high uric acid, or eGFR between 60 and 89 ml/min/1.73m²
- Healthy individuals without CKD or listed risk factors
- Voluntary signing of informed consent
You will not qualify if you...
- Patients deemed unsuitable for enrollment by the study physician
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants are observed over time to track the occurrence, development, and progression of chronic kidney disease and related risk factors.
Regular visits at multiple centers over up to 5 years
Trial Site Locations
Total: 8 locations
1
The Second People's Hospital of Nanhai District in Foshan City
Foshan, Guangdong, China
Not Yet Recruiting
2
Guangdong Provincial Peoples Hospital
Guangzhou, Guangdong, China
Actively Recruiting
3
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Not Yet Recruiting
4
Wuhua County People's Hospital
Meizhou, Guangdong, China
Not Yet Recruiting
5
Fogang County People's Hospital
Qingyuan, Guangdong, China
Not Yet Recruiting
6
People's Hospital of Yingde
Qingyuan, Guangdong, China
Not Yet Recruiting
7
Zhuhai Golden Bay Central Hospital
Zhuhai, Guangdong, China
Not Yet Recruiting
8
Ganzhou Municipal Hospital
Ganzhou, Jiangxi, China
Not Yet Recruiting
Research Team
X
Xueqing Yu, MD
F
Feng Wen, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here